| ¿µ¹® | carbohydrate | ÇÑ±Û | ź¼öȹ° |
|---|---|---|---|
| ¼³¸í | ź¼Ò¿Í ¹°ºÐÀÚ·Î ÀÌ·ç¾îÁø À¯±âÈÇÕ¹°. »ï´ë¿µ¾ç¼Ò °¡¿îµ¥ Çϳª·Î, ³ì»ö½Ä¹°ÀÇ ±¤ÇÕ¼ºÀ¸·Î »ý±ä´Ù. Æ÷µµ´ç, °ú´ç, ³ì¸» µûÀ§°¡ ÀÖ´Ù. ÀϹÝÀûÀ¸·Î ź¼Ò-¼ö¼Ò-»ê¼ÒÀÇ ¼¼ ¿ø¼Ò·Î ÀÌ·ç¾îÁö´Â ÈÇÕ¹°·Î, ³ÐÀº ¶æÀ¸·Î´Â ´ç·ù-´çÁú°ú °°Àº ¶æÀ¸·Î ¾²ÀδÙ. ÀϹݽÄ(Cn(H2O)nÀÌ ¸¶Ä¡ ź¼Ò¿Í ¹°ºÐÀÚ(H2O)·Î ÀÌ·ç¾îÁ® ÀÖ´Â °Íó·³ º¸À̱⠶§¹®¿¡ ÀÌ·± À̸§ÀÌ ºÙ¾ú´Ù. ±×¸®°í »ê¼Ò ¿øÀÚ¼ö°¡ ÀϹݽĺ¸´Ù Çϳª ÀûÀº °Í, Áú¼Ò¿øÀÚ¸¦ ÇÔÀ¯ÇÏ´Â °Í, ȲÈÇÕ¹°À» ÇÔÀ¯ÇÏ´Â °Íµµ ź¼öȹ°¿¡ Æ÷ÇÔ½ÃŲ´Ù. ÈÇÐÀûÀ¸·Î´Â ´Ù°¡ ¾ËÄÚ¿ÃÀÇ ¾Ëµ¥È÷µå ¶Ç´Â ÄÉÅæ ¹× ±× À¯µµÃ¼ÀÇ ÃÑĪÀÌ´Ù. |
||
| ¿µ¹® | test | ÇÑ±Û | °Ë»ç |
|---|---|---|---|
| ¼³¸í | ¾î¶² ´Ù¸¥ ¹°ÁúÀ» °ËÃâ, ÃøÁ¤, »ý¼ºÇϱâ À§ÇÑ Æ¯Á¤ÇÑ ÈÇйÝÀÀÀ» ÀÏÀ¸Å°´Âµ¥ »ç¿ëµÇ´Â ¹æ¹ý. |
||
| ¿µ¹® | scratch test | ÇÑ±Û | ³Àý¹ý |
|---|---|---|---|
| ¼³¸í | ÇǺθ¦ ³¯Ä«·Î¿î ¹Ù´Ã·Î ±Ü¾î ÇǺÎÀÇ ¹ÝÀÀÀ» º¸´Â °Ë»ç·Î ÇǺΠ°ú¹Î¹ÝÀÀÀ̳ª ¾Ë·¹¸£±â¸¦ ¾Ë¾Æº¸±â À§ÇÑ °Ë»çÀÌ´Ù. ¹Ù´Ã³¡¿¡ Ç׿øÀ» ¹¯Èù µÚ, ÇǺιØÀ» ±Ü¾î ¹ÝÀÀÀ» ¾Ë¾Æº»´Ù. À̶§ Ç׿øÀÌ ¾Æ´Ñ ´ëÁ¶¹°Áú(¿¹¸¦ µé¾î º¸ÅëÀÇ ¹°)À» ¹¯Èù ¹Ù´ÃÀ» °°ÀÌ ¹ÝÀÀÇÏ¿© ÇǺ馱âÁõ(dermographism) ´ÜÁö ¹Ù´ÃÀÇ ±ÜÈû¸¸À¸·Î ¾Ë·¹¸£±â °°Àº ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â Çö»ó°ú °¨º°ÇØ¾ß ÇÑ´Ù. ³Ã», û·Â¼Ò½Ç(hearing loss) û°¢ÀÌ ÀúÇÏ ¶Ç´Â »ó½ÇµÈ »óÅÂ. ¿øÀΰú Á¤µµ´Â ¿©·¯ °¡ÁöÀε¥, ³Ã»Àº ±× Á¤µµ°¡ °¡Àå ½ÉÇÑ »óÅÂÀÌ´Ù. û°¢ÀÇ Àüµµ°æ·Î¿¡ Àå¾Ö°¡ ÀÖÀ» ¶§ ³Ã»ÀÌ ÀϾ°í, ±× º´ÅͰ¡ ¿ÜÀ̵µ³ª ÁßÀÌ¿¡ ÀÖ´Â °ÍÀ» ÀüÀ½³Ã», ³»ÀÌ¿¡ ÀÖ´Â °ÍÀ» °¨À½ ³Ã»À̶ó ÇÏ¿© ±¸ºÐÇÑ´Ù. ¶Ç º´ÅÍÀÇ ÀÚ¸®¸¦ ¸í½ÃÇÏ¿© ÁßÀ̼º ³Ã»À̳ª ¹Ì·Î¼º ³Ã» µîÀ¸·Î ¼¼ºÐÇϱ⵵ ÇÑ´Ù. |
||
| ¿µ¹® | stool guaiac test | ÇÑ±Û | ´ëº¯ ±¸¾ÆÀÌ¾Ç °Ë»ç |
|---|---|---|---|
| ¼³¸í | ´ëº¯³»¿¡ ÀÖÀ» ¼ö ÀÖ´Â ÀáÇ÷(´«¿¡ º¸ÀÌÁö ¾Ê´Â ÃâÇ÷)À¯¹«¸¦ °Ë»çÇÏ´Â ¹æ¹ýÀ¸·Î, Ç÷±¸³»ÀÇ heme peroxidase¿¡ ÀÇÇØ guaiacÀÌ »êȵǴ ¹ÝÀÀÀ» ÀÌ¿ëÇÏ¿© ÃøÁ¤ÇÑ´Ù. ¹æ¹ýÀº 3Àϰ£¿¡ °ÉÃÄ ÇÑ º¯¿¡¼ 2±ºµ¥¾¿ äÃëÇÏ¿© °Ë»çÇÑ´Ù. À§¾ç¼º ¹ÝÀÀ(°ÅÁþÀ¸·Î Ç÷¾×ÀÌ ÀÖ´Ù°í ³ªÅ¸³ª´Â ¹ÝÀÀ)Àº ½Ä¹° °ú»êÈÈ¿¼Ò¸¦ ÇÔÀ¯Çϰí ÀÖ´Â È«´ç¹«ÀÇ ¼·Ã볪 Ç÷±¸ ¼ººÐÀ» ÇÔÀ¯Çϰí ÀÖ´Â °í±â ¼·Ãë µî¿¡¼ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç, À§À½¼º ¹ÝÀÀ(½ÇÁ¦·Î Ç÷¾×Àº ÀÖÁö¸¸, Ç÷¾×ÀÌ ¾ø´Ù°í ³ªÅ¸³ª´Â ¹ÝÀÀ)Àº ȯ¿ø·ÂÀ» °¡Áö°í ÀÖ´Â ºñŸ¹Î CÀÇ º¹¿ë½Ã ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ƯÈ÷ À§¾ç¼º ¹ÝÀÀÀÌ ¸Å¿ì ÈçÇÏ´Ù. |
||
| ¿µ¹® | Rorschach Test | ÇÑ±Û | ·Î¸£»þÇÏ °Ë»ç |
|---|---|---|---|
| ¼³¸í | »ç°íÀå¾Ö¿Í Á¤¼Àå¾Ö¿¡ ¹Î°¨ÇÑ Åõ»ç°Ë»ç(projective test). °ËÀº»ö°ú ¸î°¡Áö »öÀ¸·Î ÀÌ·ç¾îÁø À×Å©¾ó·è°°Àº µµÇüÀÌ ±×·ÁÁø 10°³ÀÇ Ä«µå¸¦ ÀÌ¿ëÇÑ´Ù. ÇǰËÀÚ¿¡°Ô Ä«µå¸¦ º¸ÀÌ°í º» °Í¿¡ ´ëÇØ ¸»Çϵµ·Ï ÇÑ´Ù. ´ÙÀ½¿¡´Â ¾ó·èÀÇ ¾î´À À§Ä¡°¡ ÇǰËÀÚ°¡ ¸»ÇÑ Áö°¢´ë»óÀ» ¾Ï½ÃÇÏ´ÂÁö ãµµ·Ï ÇÑ´Ù. ÇǰËÀÚÀÇ ´äº¯À» ºÐ¼®ÇÏ¸é ±×ÀÇ »ç°í¿Í Á¤¼»óÅ¿¡ ´ëÇÑ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ´Ù. |
||
| PAT | Pain Apperception Test; paroxysmal atrial tachycardia; patient; phenylaminotetrazole; physical abili... |
|---|---|
| CAT | California Achievement Test; capillary agglutination test; catalase; cataract; catecholamine; Childr... |
| TAT | tetanus antitoxin; thematic apperception test; thematic aptitude test; thrombin-antithrombin complex... |
| Bz-Ty-PABA test | N-Benzoyl-L-Tyrosyl-p-Amino-Benzoic Acid test = Bentiromide test = Tr... |
| DAT | delayed-action tablet; dementia Alzheimer's type; dental aptitude test; diacetylthiamine; diet as to... |
| CGU | Cerebral glucose utilization |
|---|---|
| DUR | Drug Utilization Review |
| GUSTO-I | Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries |
| GU | Glucose utilization |
| NMCUES | National Medical Care Utilization and Expenditure Survey |
| carbohydrate utilization test | A test for the definitive identification of clinically important yeasts and yeastlike organisms. (05 Mar 2000) |
|---|
| drug utilization | The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles. (12 Dec 1998) |
|---|---|
| drug utilization review | Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for medicaid programs beginning in 1993. (12 Dec 1998) |
| oxygen utilization coefficient | The extraction coefficient for oxygen in any given tissue. (05 Mar 2000) |
| utilization review | An organised procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use. (12 Dec 1998) |
| utilization time | The minimum duration of a stimulus of rheobasic strength that is just sufficient to produce excitation. Synonym: temps utile. (05 Mar 2000) |
| antigens, tumour-associated, carbohydrate | Carbohydrate antigens expressed by malignant tissue. They are useful as tumour markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. (12 Dec 1998) |
| carbohydrate | <biochemistry> Very abundant compounds, usually an aldehyde or ketone derivative of a polyhydric alcohol, particularly of the pentahydric and hexahydric alcohols. They are so named because the hydrogen and oxygen are usually in the proportion to form water with the general formula Cn(H2O)n. The most important carbohydrates are the starches, sugars, celluloses and gums. They are classified into mono, di, tri, poly and heterosaccharides. The smallest are monosaccharides like glucose whereas polysaccharides such as starch, cellulose or glycogen can be large and indeterminate in length. (08 Oct 1997) |
| carbohydrate conformation | The characteristic 3-dimensional shape of a carbohydrate. (12 Dec 1998) |
| carbohydrate-deficient glycoprotein syndrome | <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors. (12 Dec 1998) |
| carbohydrate dehydrogenases | <enzyme> Reversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Registry number: EC 1.1. (12 Dec 1998) |
| carbohydrate epimerases | <enzyme> Enzymes that catalyze the epimerization of chiral centres within carbohydrates or their derivatives. Registry number: EC 5.1.3 (12 Dec 1998) |
| carbohydrate-induced hyperlipaemia | type III familial hyperlipoproteinaemia, type IV familial hyperlipoproteinaemia |
| carbohydrate loading | A procedure popular with long-distance runners and other athletes of filling muscles with a large glycogen pool prior to an athletic event; often, the athlete consumes very few carbohydrates for three days followed by a largely carbohydrate diet for the last three days before the event. (05 Mar 2000) |
| carbohydrate metabolism | <biochemistry> The breakdown of starches and sugars into smaller units that can be used by the body for energy. (27 Sep 1997) |
| carbohydrate sequence | The sequence of carbohydrates within polysaccharides, glycoproteins, and glycolipids. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|